This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lim, C. S. Articles by Swain, J. L. Search for Related Content PubMed PubMed Citation Articles by Lim, C. S. Articles by Swain, J. L.

Circulation, Vol 83, 2007-2011, Copyright © 1991 by American Heart Association

ARTICLES

Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog

CS Lim, GD Chapman, RS Gammon, JB Muhlestein, RP Bauman, RS Stack and JL Swain
Department of Medicine, Duke University Medical Center, Durham, N.C. 27710.

Gene therapy approaches have been suggested for the treatment of cardiovascular disease. Recently, direct transfer of the gene encoding beta-galactosidase into peripheral arteries of the pig has been demonstrated. To determine whether this approach is applicable to other arterial beds and to other species, we first evaluated the use of beta- galactosidase as a marker protein in the canine model. We demonstrate that variable but substantial endogenous beta-galactosidase-like activity is induced by manipulation of canine peripheral arteries, which precludes the use of this marker protein in evaluating the efficiency of gene transfer in this model. A marker gene encoding firefly luciferase was then evaluated, and background luciferase activity was found to be low in the dog even after arterial manipulation. Using the luciferase gene, we then demonstrated lipid- mediated gene transfer directly into both coronary and peripheral arteries of the intact dog. These results indicate the feasibility of in vivo gene transfer into coronary arteries and demonstrate the use of the luciferase marker protein in quantifying recombinant protein expression following gene transfer in canine models. This simple and effective method for direct in vivo gene transfer into coronary and peripheral arteries may be applicable to the localized production of therapeutically important proteins for the treatment of cardiovascular diseases.

This article has been cited by other articles:

				H. Ooboshi, S. Ibayashi, J. Takada, H. Yao, T. Kitazono, and M. Fujishima Adenovirus-Mediated Gene Transfer to Ischemic Brain : Ischemic Flow Threshold for Transgene Expression Stroke, April 1, 2001; 32(4): 1043 - 1047. [Abstract] [Full Text] [PDF]

				S. L. Meyerson, C. L. Skelly, M. A. Curi, and L. B. Schwartz Gene Therapy for Cardiovascular Disease Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2000; 4(4): 289 - 300. [Abstract] [PDF]

				L. J Feldman and G. Steg Optimal techniques for arterial gene transfer Cardiovasc Res, September 1, 1997; 35(3): 391 - 404. [Abstract] [Full Text] [PDF]

				G. Vassalli and D. A Dichek Gene therapy for arterial thrombosis Cardiovasc Res, September 1, 1997; 35(3): 459 - 469. [Abstract] [Full Text] [PDF]

				M. G. Davies, B. H. Annex, G. J. Fulton, S. M. Denning, D. A. Taylor, M. A. Blazing, K. G. Peters, K. M. Channon, S. E. George, and P.-O. Hagen Alteration of Arterial Vasomotor Function in Vitro by Gene Transfer with a Replication-Deficient Adenovirus Vascular and Endovascular Surgery, March 1, 1997; 31(2): 131 - 136. [Abstract] [PDF]

				V. J. Dzau and M. Horiuchi In Vivo Gene Transfer and Gene Modulation in Hypertension Research Hypertension, December 1, 1996; 28(6): 1132 - 1137. [Abstract] [Full Text]

				C. J. Magovern, C. A. Mack, J. Zhang, R. T. Hahn, W. Ko, O. W. Isom, R. G. Crystal, and T. K. Rosengart Direct In Vivo Gene Transfer to Canine Myocardium Using a Replication-Deficient Adenovirus Vector Ann. Thorac. Surg., August 1, 1996; 62(2): 425 - 433. [Abstract] [Full Text]

				R. R. Makkar, N. Eigler, F. Litvack, and J. S. Forrester Prevention of Restenosis by Local Drug Delivery Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 1996; 1(2): 177 - 188. [Abstract] [PDF]

				J. Lee, H. Laks, D. C. Drinkwater, A. Blitz, L. Lam, Y. Shiraishi, P. Chang, T. A. Drake, and A. Ardehali CARDIAC GENE TRANSFER BY INTRACORONARY INFUSION OF ADENOVIRUS VECTOR--MEDIATED REPORTER GENE IN THE TRANSPLANTED MOUSE HEART J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 246 - 252. [Abstract] [Full Text]

				R. T. Rowland, J. C. Cleveland Jr, X. Meng, A. H. Harken, and J. M. Brown Potential Gene Therapy Strategies in the Treatment of Cardiovascular Disease Ann. Thorac. Surg., September 1, 1995; 60(3): 721 - 728. [Abstract] [Full Text]

				H. Ooboshi, M. J. Welsh, C. D. Rios, B. L. Davidson, and D. D. Heistad Adenovirus-Mediated Gene Transfer In Vivo to Cerebral Blood Vessels and Perivascular Tissue Circ. Res., July 1, 1995; 77(1): 7 - 13. [Abstract] [Full Text]

				A. Ardehali, A. Fyfe, H. Laks, D. C. Drinkwater Jr., J.-H. Qiao, and A. J. Lusis Direct gene transfer into donor hearts at the time of harvest J. Thorac. Cardiovasc. Surg., April 1, 1995; 109(4): 716 - 720. [Abstract] [Full Text]

				E. G. Nabel Gene Therapy for Cardiovascular Disease Circulation, January 15, 1995; 91(2): 541 - 548. [Full Text]

				A. H. Harken and D. E. Harken Cardiothoracic Surgery JAMA, July 15, 1992; 268(3): 337 - 338. [Abstract] [PDF]

				Y. Taniyama, K. Tachibana, K. Hiraoka, T. Namba, K. Yamasaki, N. Hashiya, M. Aoki, T. Ogihara, K. Yasufumi, and R. Morishita Local Delivery of Plasmid DNA Into Rat Carotid Artery Using Ultrasound Circulation, March 12, 2002; 105(10): 1233 - 1239. [Abstract] [Full Text] [PDF]